March 29, 2011 (Washington, DC and Dallas, Texas) — The American College of Cardiology and the American Heart Association have updated the 2007 Guidelines for the Management of Patients with Unstable ...
The results of the Clopidogrel Medco Outcomes Study, [8] presented at The Society for Cardiovascular Angiography and Interventions (SCAI) meeting in May 2009, prompted the SCAI to issue a ...
CHICAGO -- For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more effective and at least as safe as aspirin monotherapy in a high-risk ...
A research team led by Professors Joo-Yong Hahn, Young Bin Song, and Ki Hong Choi of the Division of Cardiology at Samsung Medical Center, Sungkyunkwan University School of Medicine, together with ...
LONDON (Reuters) - AstraZeneca's experimental heart drug Brilinta has proved superior to Sanofi-Aventis and Bristol-Myers Squibb's blockbuster Plavix in a pivotal clinical trial. Topline results from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results